EXTRAPYRAMIDAL MOTOR ABNORMALITIES ASSOCIATED WITH LATE-LIFE PSYCHOSIS

被引:17
作者
CALIGIURI, MP
LOHR, JB
PANTON, D
HARRIS, MJ
机构
[1] VET AFFAIRS MED CTR, GERIATR PSYCHIAT SERV, SAN DIEGO, CA USA
[2] SOUTHWOOD PSYCHIAT HOSP, SAN DIEGO, CA USA
[3] UNIV CALIF SAN DIEGO, SCH MED, DEPT PSYCHIAT, LA JOLLA, CA 92093 USA
关键词
D O I
10.1093/schbul/19.4.747
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Studies of extrapyramidal motor function in patients with schizophrenia have contributed to our understanding of the phenomenology and therapeutic outcome associated with neuroleptics. An increasing body of literature suggests that extrapyramidal motor abnormalities associated with schizophrenia may be linked to the pathophysiological mechanisms responsible for schizophrenia. Similarly, it has been documented that the extrapyramidal system may be involved in motor abnormalities in patients with Alzheimer's disease (AD). The present study was undertaken to examine motor function in schizophrenia and AD patients with psychosis. Quantitative instrumental procedures were used to examine rigidity, tremor, and bradykinesia in 13 neuroleptic-naive patients with schizophrenia, 13 AD patients with psychosis, and 26 age-comparable controls. Both schizophrenia and AD patients had significantly higher tremor and rigidity scores than did normal subjects. This comparative study of schizophrenia and AD patients with psychosis suggests that the effect of dementia in patients with psychosis is to prolong movement time, whereas abnormal parkinsonian postural tremor tends to be associated with psychosis in the absence of dementia.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 33 条
[1]  
*AM PSYCH ASS, 1987, DSMIIIR DIAGN STAT M
[2]   POSITIVE VS NEGATIVE SCHIZOPHRENIA - A CRITICAL-EVALUATION [J].
ANDREASEN, NC .
SCHIZOPHRENIA BULLETIN, 1985, 11 (03) :380-389
[3]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[4]   INCREASED DOPAMINE CONCENTRATION IN LIMBIC AREAS OF BRAIN FROM PATIENTS DYING WITH SCHIZOPHRENIA [J].
BIRD, ED ;
SPOKES, EGS ;
IVERSEN, LL .
BRAIN, 1979, 102 (JUN) :347-360
[5]  
BIRD ED, 1984, CLIN NEUROPHARMAC S1, V7, P910
[6]  
BRACHA HS, 1986, PSYCHIAT CLIN N AM, V9, P133
[7]   NEUROLOGICAL SIGNS IN ALZHEIMERS-DISEASE [J].
BURNS, A ;
JACOBY, R ;
LEVY, R .
AGE AND AGEING, 1991, 20 (01) :45-51
[8]  
CALIGIURI MP, 1993, AM J PSYCHIAT, V150, P1343
[9]   QUANTIFYING DRUG-INDUCED CHANGES IN PARKINSONIAN RIGIDITY USING AN INSTRUMENTAL MEASURE OF ACTIVATED STIFFNESS [J].
CALIGIURI, MP ;
GALASKO, DR .
CLINICAL NEUROPHARMACOLOGY, 1992, 15 (01) :1-12
[10]   CLINICAL AND INSTRUMENTAL ASSESSMENT OF NEUROLEPTIC-INDUCED PARKINSONISM IN PATIENTS WITH TARDIVE-DYSKINESIA [J].
CALIGIURI, MP ;
LOHR, JB ;
BRACHA, HS ;
JESTE, DV .
BIOLOGICAL PSYCHIATRY, 1991, 29 (02) :139-148